RecruitingNot ApplicableNCT02813642

Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients

Evaluation of Non Traditional Cardiovascular Risk Factors in Chronic Kidney Disease Patients Starting Dialysis


Sponsor

University Hospital, Montpellier

Enrollment

400 participants

Start Date

Dec 8, 2011

Study Type

INTERVENTIONAL

Conditions

Summary

To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at heart disease risk factors in patients who are just starting dialysis — a treatment that cleans the blood when the kidneys can no longer do it — to better understand how to protect the heart health of people with advanced kidney failure. **You may be eligible if...** - You have advanced kidney disease and are just beginning dialysis treatment - You have signed a written consent form **You may NOT be eligible if...** - You are pregnant - You have chronic kidney disease but are not yet on dialysis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALPlasma osteoprotegerin level

dosage of plasma osteoprotegerin

BIOLOGICALPlasma fibroblast growth factor 23 level

dosage of plasma fibroblast growth factor 23

PROCEDUREVascular calcification score

measurement of vascular calcification score by X-ray of the lateral abdominal aorta


Locations(5)

Centre Hémodialyse du Lez

Castelnau-le-Lez, France

AIDER

Montpellier, France

CHU Montpellier, Nephrology department

Montpellier, France

CH Nimes, Nephrology department

Nîmes, France

CH Perpignan, Nephrology department

Perpignan, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02813642


Related Trials